Hypertensive Heart Disease in DR Congo

July 24, 2024 updated by: Association of Future African Neurosurgeons, Yaounde, Cameroon

Comorbidities and the Management of Hypertensive Heart Disease in a Low-Resource Setting: A Cross-Sectional Study

In this Cross-sectional study, we will analyzed data from a tertiary referral Congolese hospital to find whether or not Congolese patients with hypertensive heart disease have multiple comorbid conditions. Will report on the management and outcomes of the patients.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This will be done by collecting individual data on BMI, dyslipidemia, stroke, diabetes, serum creatinine, HDL, LDL, and urea levels for patients diagnosed with hypertensive heart disease.

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

All patients 18 year or older diagnosed with hypertensive heart disease at Monkole Mother and Infant Hospital Center from January to December 2019

Description

Inclusion Criteria:

  • Patients is 18 year or older
  • Patient is diagnosed with hypertensive heart disease

Exclusion Criteria:

  • Patient is not 18 year or older
  • Patient is not diagnosed with hypertensive heart disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
High Systolic Blood Pressure
Time Frame: 1 month
The study will use high systolic blood pressures as a measure for hypertensive heart disease.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Association of Future African Neurosurgeons, Yaounde, Cameroon

Investigators

  • Principal Investigator: Raïssa K Kongue, MD, Faculty of Medicine, Bel Campus University of Technology, Kinshasa, Democratic Republic of Congo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 26, 2024

Primary Completion (Estimated)

July 28, 2024

Study Completion (Estimated)

July 29, 2024

Study Registration Dates

First Submitted

July 24, 2024

First Submitted That Met QC Criteria

July 24, 2024

First Posted (Actual)

July 29, 2024

Study Record Updates

Last Update Posted (Actual)

July 29, 2024

Last Update Submitted That Met QC Criteria

July 24, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AAfricanNeuro

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The IPD from this study will be openly available in the Open Science Framework.

IPD Sharing Time Frame

It will be indefinitely available after the study has been conducted.

IPD Sharing Access Criteria

This data will be open to all individuals.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertensive Heart Disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe